Search results
Microdosing Magic Mushrooms: Here's What the Health Experts Have to Say
Eating Well via Yahoo News· 3 days ago“Microdosing is just how it sounds—a...CDCES, registered dietitian and diabetes care and education...
New Study Links Depression and Weight Gain — Here Are 3 MD-Approved Ways to Restore Your Health
First for Women via Yahoo News· 6 days agoIndeed, a study published in the British Journal of Sports Medicine found that daily exercise was...
Mum diagnosed with epilepsy after symptoms dismissed as panic attacks
Yahoo Life UK· 5 days ago(SWNS) Madeleine Dippnall A mum has been diagnosed with epilepsy after her symptoms were initially...
Antidepressants Differ by Long-Term Response in Major Depression
Psychiatric Times· 7 days agoAntidepressants differ in improving symptoms and preventing relapse of major depressive disorder...
Long-COVID patients more likely to report psychiatric symptoms, cost barriers to therapy
Center for Infectious Disease Research and Policy· 3 days agoA study in JAMA Network Open finds that while US adults with long COVID have a higher rate of...
Symptom diary: Potential benefits, tips to start one, and more
Medical News Today· 6 days agoA symptom diary can be a useful tool for recording symptoms. It can be used to monitor an existing...
Can Esketamine Prevent Postpartum Depression?
Medscape· 3 days agoData suggest that a low dose of esketamine immediately after childbirth reduces major depressive episodes in women with prenatal depression.
Positive childhood experiences can boost mental health and reduce depression and anxiety in teens
Medical Xpress· 2 days agoStudents were asked to note their number of positive and adverse experiences (up to age 18), the...
New Redwood City outpatient center treats mental health, substance use
San Mateo Daily Journal· 49 minutes agoEvan Amarni, CEO and co-founder, said individualizing treatment allows for a better chance at...
Neurocrine reports promising phase 2 depression drug data By Investing.com
Investing.com· 6 days ago(NASDAQ:NBIX) announced today that its Phase 2 study for the investigational drug NBI-1065845 has...